Treatment de-intensification for low-risk biochemical recurrence after radical prostatectomy: rational or risky?
- PMID: 37303121
- DOI: 10.1111/bju.16086
Treatment de-intensification for low-risk biochemical recurrence after radical prostatectomy: rational or risky?
References
-
- Mottet N, Bellmunt J, Briers E et al. EAU - ESTRO - ESUR - SIOG Guidelines on Prostate Cancer. Arnhem, The Netherlands: EAU Guidelines Office, 2022
-
- Adam M, Tennstedt P, Lanwehr D et al. Functional outcomes and quality of life after radical prostatectomy only versus a combination of prostatectomy with radiation and hormonal therapy. Eur Urol 2017; 71: 330-6
-
- Fendler WP, Calais J, Eiber M et al. Assessment of 68Ga-PSMA-11 PET accuracy in localizing recurrent prostate cancer: A prospective single-arm clinical trial. JAMA Oncol 2019; 5: 856-63
-
- Emmett L, Tang R, Nandurkar R et al. 3-year freedom from progression after (68)Ga-PSMA PET/CT-triaged Management in men with biochemical recurrence after radical prostatectomy: Results of a prospective multicenter trial. J Nucl Med 2020; 61: 866-72
-
- Roberts MJ, Chatfield MD, Hruby G et al. Event-free survival after radical prostatectomy according to prostate-specific membrane antigen-positron emission tomography and European Association of Urology biochemical recurrence risk groups. BJU Int 2022; 130(Suppl 3): 32-9
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
